248 related articles for article (PubMed ID: 24837548)
1. Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies.
Nakamura Y; Maekawa T; Felizola SJ; Satoh F; Qi X; Velarde-Miranda C; Plonczynski MW; Ise K; Kikuchi K; Rainey WE; Gomez-Sanchez EP; Gomez-Sanchez CE; Sasano H
Mol Cell Endocrinol; 2014 Jul; 392(1-2):73-9. PubMed ID: 24837548
[TBL] [Abstract][Full Text] [Related]
2. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas.
Fallo F; Pezzi V; Barzon L; Mulatero P; Veglio F; Sonino N; Mathis JM
Eur J Endocrinol; 2002 Dec; 147(6):795-802. PubMed ID: 12457455
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.
Nishimoto K; Koga M; Seki T; Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE; Naruse M; Sakaguchi T; Morita S; Kosaka T; Oya M; Ogishima T; Yasuda M; Suematsu M; Kabe Y; Omura M; Nishikawa T; Mukai K
Mol Cell Endocrinol; 2017 Feb; 441():124-133. PubMed ID: 27751767
[TBL] [Abstract][Full Text] [Related]
6. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues.
Felizola SJ; Nakamura Y; Ono Y; Kitamura K; Kikuchi K; Onodera Y; Ise K; Takase K; Sugawara A; Hattangady N; Rainey WE; Satoh F; Sasano H
J Mol Endocrinol; 2014 Apr; 52(2):159-67. PubMed ID: 24403568
[TBL] [Abstract][Full Text] [Related]
7. Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3.
Gomez-Sanchez CE; Qi X; Gomez-Sanchez EP; Sasano H; Bohlen MO; Wisgerhof M
Mol Cell Endocrinol; 2017 Jan; 439():74-80. PubMed ID: 27793677
[TBL] [Abstract][Full Text] [Related]
8. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
9. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
[TBL] [Abstract][Full Text] [Related]
10. Isoform-specific monoclonal antibodies against 3β-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism.
Doi M; Satoh F; Maekawa T; Nakamura Y; Fustin JM; Tainaka M; Hotta Y; Takahashi Y; Morimoto R; Takase K; Ito S; Sasano H; Okamura H
J Clin Endocrinol Metab; 2014 Feb; 99(2):E257-62. PubMed ID: 24423300
[TBL] [Abstract][Full Text] [Related]
11. The Age-Dependent Changes of the Human Adrenal Cortical Zones Are Not Congruent.
Tezuka Y; Atsumi N; Blinder AR; Rege J; Giordano TJ; Rainey WE; Turcu AF
J Clin Endocrinol Metab; 2021 Apr; 106(5):1389-1397. PubMed ID: 33524149
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17.
Nakamura Y; Kitada M; Satoh F; Maekawa T; Morimoto R; Yamazaki Y; Ise K; Gomez-Sanchez CE; Ito S; Arai Y; Dezawa M; Sasano H
Mol Cell Endocrinol; 2016 Feb; 422():57-63. PubMed ID: 26597777
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma.
Karashima S; Takeda Y; Cheng Y; Yoneda T; Demura M; Kometani M; Ohe M; Mori S; Yagi K; Yamagishi M
Steroids; 2011 Nov; 76(12):1363-6. PubMed ID: 21801737
[TBL] [Abstract][Full Text] [Related]
14. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
Gomez-Sanchez CE; Gomez-Sanchez EP; Nishimoto K
Horm Metab Res; 2020 Jun; 52(6):421-426. PubMed ID: 32289837
[TBL] [Abstract][Full Text] [Related]
16. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
Enberg U; Farnebo LO; Wedell A; Gröndal S; Thorén M; Grimelius L; Kjellman M; Bäckdahl M; Hamberger B
World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical zonation in humans under normal and pathological conditions.
Nishimoto K; Nakagawa K; Li D; Kosaka T; Oya M; Mikami S; Shibata H; Itoh H; Mitani F; Yamazaki T; Ogishima T; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2010 May; 95(5):2296-305. PubMed ID: 20200334
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.
Iwahashi N; Umakoshi H; Seki T; Gomez-Sanchez CE; Mukai K; Suematsu M; Umezawa Y; Oya M; Kosaka T; Seki M; Suzuki Y; Horiuchi Y; Ogawa Y; Nishimoto K
J Clin Endocrinol Metab; 2022 Aug; 107(9):2439-2448. PubMed ID: 35796577
[TBL] [Abstract][Full Text] [Related]
19. Functional maturation of the primate fetal adrenal in vivo: 3. Specific zonal localization and developmental regulation of CYP21A2 (P450c21) and CYP11B1/CYP11B2 (P450c11/aldosterone synthase) lead to integrated concept of zonal and temporal steroid biosynthesis.
Coulter CL; Jaffe RB
Endocrinology; 1998 Dec; 139(12):5144-50. PubMed ID: 9832454
[TBL] [Abstract][Full Text] [Related]
20. Development of monoclonal antibodies against human CYP11B1 and CYP11B2.
Gomez-Sanchez CE; Qi X; Velarde-Miranda C; Plonczynski MW; Parker CR; Rainey W; Satoh F; Maekawa T; Nakamura Y; Sasano H; Gomez-Sanchez EP
Mol Cell Endocrinol; 2014 Mar; 383(1-2):111-7. PubMed ID: 24325867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
